๐ฐ Applied Dna Sciences News
Page 7 - Applied Dna Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Applied Dna Sciences. Real-time updates on events, politics, business and more.
April 7, 2023
Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, announced that its CertainT® supply chain traceability platform is featured in an article on the home page of the New York... | April 7, 2023
April 4, 2023
StockNews.com upgraded shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) from a sell rating to a hold rating in a research report released on Friday morning. APDN has been the topic of several other research reports. HC Wainwright reissued a buy rating and issued a $5.00 target price on shares of Applied DNA Sciences […]
March 29, 2023
Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that it has established a new high bar for the production of DNA with the manufacture and shipment of a... | March 29, 2023
March 28, 2023
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 23, 2023, Applied DNA Sciences,... | March 28, 2023
March 27, 2023
StockNews.com upgraded shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) from a sell rating to a hold rating in a research note published on Thursday. Other research analysts have also issued research reports about the company. Maxim Group reduced their price target on Applied DNA Sciences from $6.00 to $3.00 in a report on […]
March 27, 2023
HC Wainwright restated their buy rating on shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $5.00 price objective on the technology company’s stock. Other research analysts have also recently issued research reports about the company. Maxim Group cut their […]
March 26, 2023
StockNews.com upgraded shares of Applied DNA Sciences (NASDAQ:APDN – Get Rating) from a sell rating to a hold rating in a research report released on Thursday morning. Several other research firms have also recently weighed in on APDN. Maxim Group decreased their target price on Applied DNA Sciences from $6.00 to $3.00 in a research […]
February 9, 2023
- Maintains Timeline to cGMP Capacity, Initiates Build-out of Cost-Efficient Facility - - Business Update Conference Call/Webcast Scheduled for Today at 4:30 PM ET - ... | February 9, 2023
October 11, 2022
Applied DNA Sciences, Inc. announced that it received its large single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply... | October 11, 2022
September 7, 2022
07.09.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (โApplied DNAโ or the โCompanyโ), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on ...